FPRL1 as a Coreceptor for HIV/SIV
Author Information
Author(s): Shimizu Nobuaki, Tanaka Atsushi, Mori Takahisa, Ohtsuki Takahiro, Hoque Aliful, Jinno-Oue Atsushi, Apichartpiyakul Chatchawann, Kusagawa Shigeru, Takebe Yutaka, Hoshino Hiroo
Primary Institution: Gunma University Graduate School of Medicine
Hypothesis
FPRL1 acts as a coreceptor for primary isolates of HIV-1 and other HIV/SIV strains.
Conclusion
FPRL1 is a novel and efficient coreceptor for HIV/SIV strains, playing both protective and promotive roles in HIV-1 infection.
Supporting Evidence
- FPRL1 was found to be efficiently used as a coreceptor by primary HIV-1 isolates.
- Activated monocytes expressing FPRL1 become resistant to infection by HIV-1 strains.
- FPRL1's coreceptor activity was partially blocked by the fMLF peptide.
Takeaway
FPRL1 helps HIV get into cells, and it can both protect and help the virus depending on the situation.
Methodology
The study involved transducing a human glioma cell line with FPRL1 and testing its susceptibility to various HIV/SIV strains.
Limitations
The roles of FPRL1 in HIV-1 infection in vivo need further investigation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website